Advance in Photosensitizers and Light Delivery for Photodynamic Therapy.
- Author:
Il YOON
1
;
Jia Zhu LI
;
Young Key SHIM
Author Information
- Publication Type:In Vitro ; Review
- Keywords: Photochemotherapy; Photosensitizing agents; Chlorophyll and chlorins; Photothermal therapy; Light delivery
- MeSH: Chlorophyll; Dihematoporphyrin Ether; Family Characteristics; Light; Photochemotherapy; Photosensitizing Agents; Porphyrins; Triazenes
- From:Clinical Endoscopy 2013;46(1):7-23
- CountryRepublic of Korea
- Language:English
- Abstract: The brief history of photodynamic therapy (PDT) research has been focused on photosensitizers (PSs) and light delivery was introduced recently. The appropriate PSs were developed from the first generation PS Photofrin (QLT) to the second (chlorins or bacteriochlorins derivatives) and third (conjugated PSs on carrier) generations PSs to overcome undesired disadvantages, and to increase selective tumor accumulation and excellent targeting. For the synthesis of new chlorin PSs chlorophyll a is isolated from natural plants or algae, and converted to methyl pheophorbide a (MPa) as an important starting material for further synthesis. MPa has various active functional groups easily modified for the preparation of different kinds of PSs, such as methyl pyropheophorbide a, purpurin-18, purpurinimide, and chlorin e6 derivatives. Combination therapy, such as chemotherapy and photothermal therapy with PDT, is shortly described here. Advanced light delivery system is shown to establish successful clinical applications of PDT. Phtodynamic efficiency of the PSs with light delivery was investigated in vitro and/or in vivo.
